176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-13.23%
Cash & equivalents declining -13.23% while AVGO's grows 13.15%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
-0.37%
Both AVGO and the company show zero Short-Term Investments Growth.
-4.15%
Below half of AVGO's 13.15%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
24.76%
Receivables growth less than half of AVGO's -26.18%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
11.45%
Inventory growth 1.25-1.5x AVGO's 8.08%. Martin Whitman worries about slower turnover or potential markdown risk.
No Data
No Data available this quarter, please select a different quarter.
5.66%
Below half of AVGO's 12.70%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-0.43%
Similar yoy growth to AVGO's -0.45%. Walter Schloss sees parallel capital spending strategies. Check utilization rates.
-0.42%
Higher Goodwill Growth compared to AVGO's zero value, indicating worse performance.
-3.60%
50-75% of AVGO's -5.63%. Bruce Berkowitz notes moderate intangible additions. Check if growth is organically driven.
-3.60%
Above 1.5x AVGO's -1.53%. Michael Burry sees potential overpaying or intangible bubble risk. Check synergy assumptions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.75%
Less than half of AVGO's 4.04%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-1.82%
1.25-1.5x AVGO's -1.28%. Bruce Berkowitz checks if expansions surpass competitor's pace but remain justified.
No Data
No Data available this quarter, please select a different quarter.
3.97%
≥ 1.5x AVGO's 0.60%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
17.81%
Above 1.5x AVGO's 10.41%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-33.27%
Less than half of AVGO's -74.69%. David Dodd sees much smaller short-term leverage burden vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.99%
Less than half of AVGO's -18.90%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
142.80%
Similar yoy changes to AVGO's 147.44%. Walter Schloss sees parallel expansions in other LT liabilities.
37.64%
Above 1.5x AVGO's 1.60%. Michael Burry sees a strong spike vs. competitor. Check coverage and debt ratios.
No Data
No Data available this quarter, please select a different quarter.
11.80%
Less than half of AVGO's -2.84%. David Dodd sees far fewer liability expansions relative to competitor.
0.60%
Higher Common Stock (Book Value) Growth compared to AVGO's zero value, indicating worse performance.
5.19%
Below half AVGO's 50.41%. Michael Burry suspects major net losses or high dividends vs. competitor.
25.60%
Above 1.5x AVGO's 7.28%. Michael Burry sees a significant jump in intangible or market-based gains. Scrutinize risk of reversal.
No Data
No Data available this quarter, please select a different quarter.
1.21%
Below half AVGO's 5.30%. Michael Burry sees potential underperformance in building shareholder capital.
3.97%
≥ 1.5x AVGO's 0.60%. David Dodd sees faster overall balance sheet growth than competitor.
-0.37%
Both AVGO and the company show zero Total Investments Growth.
-33.27%
Above 1.5x AVGO's -4.54%. Michael Burry sees a major jump. Investigate leverage rationale.
13.00%
Less than half of AVGO's -7.44%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
